Sage Therapeutics Inc (FRA:SG7)
€ 5.452 0.102 (1.91%) Market Cap: 325.18 Mil Enterprise Value: -211.07 Mil PE Ratio: 0 PB Ratio: 0.61 GF Score: 49/100

SAGE Therapeutics Inc at JPMorgan Healthcare Conference Transcript

Jan 09, 2024 / 12:30AM GMT
Release Date Price: €23.8 (+20.81%)
Anupam Rama
JPMorgan Chase & Co, Research Division - VP and Analyst

Welcome, everyone, 42nd JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by my squad, [Malcolm Cloonan], Lauren Hall and Priyanka Grover. Our next presenting company is Sage Therapeutics. I'm presenting on behalf of the company, we have CEO, Barry Greene. Sorry, I was just a little flustered with that music, yeah so, my bad man that wasâ¦

Barry E. Greene
Sage Therapeutics, Inc. - President, CEO & Director

Don't be flustered Anupam.

Anupam Rama
JPMorgan Chase & Co, Research Division - VP and Analyst

Not great delivery.

Barry E. Greene
Sage Therapeutics, Inc. - President, CEO & Director

And look, Anupam, thanks for having us, and I'd like to thank the organizers of JPMorgan for having us here today. It's great to be back with all of you in San Francisco, and it's not raining for those of you that that aren't here

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot